Table 3.
Demographics and clinical characteristics in transplant recipients
| Parameter | Black | White | P |
|---|---|---|---|
| n (%) | 195 (4) | 4841 (96) | |
| Age (yr; median [IQR]) | 43 (30 to 52) | 45 (35 to 55) | 0.0400a |
| Male | 129 (66) | 3104 (64) | 0.5600 |
| Cause of ESRD, n (%) | |||
| diabetic nephropathy | 38 (19) | 984 (20) | 0.7800 |
| glomerulonephritis | 55 (28) | 1540 (32) | 0.2900 |
| hypertensive/ischemic renal disease | 43 (22) | 343 (7) | <0.0001 |
| polycystic kidney disease | 11 (6) | 636 (13) | 0.0020 |
| other | 48 (25) | 1338 (28) | 0.3500 |
| Comorbidity, n (%)b | |||
| diabetesc | 7 (4) | 116 (2) | 0.2900 |
| coronary diseased | 22 (11) | 439 (9) | 0.2900 |
| chronic heart failure | 30 (15) | 459 (9) | 0.0060 |
| stroke or TIA | 9 (5) | 120 (2) | 0.0600 |
| chronic lung disease | 2 (1) | 120 (2) | 0.2000 |
| peripheral vascular disease | 6 (3) | 176 (4) | 0.6800 |
| malignancy | 4 (2) | 125 (3) | 0.6500 |
| Current smoker, n (%) | 12 (6) | 748 (15) | 0.0004 |
| Initial peritoneal dialysis modality, n (%) | 61 (31) | 1655 (34) | 0.400 |
| Lowest quintile of SES | 70 (36) | 961 (20) | <0.0001 |
| Rural | 4 (2) | 1032 (21) | <0.0001 |
| Geographic region, n (%) | |||
| Atlantic Canada | 8 (4) | 482 (10) | 0.0070 |
| Quebec | 40 (21) | 1182 (24) | 0.2100 |
| Ontario | 115 (59) | 1747 (36) | <0.0001 |
| Manitoba | 2 (1) | 145 (3) | 0.1100 |
| Saskatchewan | 1 (1) | 175 (4) | 0.0200 |
| Alberta | 18 (9) | 519 (11) | 0.5100 |
| British Columbia | 11 (6) | 591 (12) | 0.0060 |
| Year of dialysis initiation, n (%) | |||
| 1990 to 1992 | 46 (24) | 1217 (25) | 0.6200 |
| 1993 to 1994 | 35 (18) | 914 (19) | 0.7400 |
| 1995 to 1996 | 44 (23) | 920 (19) | 0.2200 |
| 1997 to 1998 | 38 (19) | 962 (20) | 0.8900 |
| 1999 to 2000 | 32 (16) | 828 (17) | 0.8000 |
a
Kruskal-Wallis test; all others χ2 test.
b
Comorbidity data collected at dialysis initiation.
c
In participants for whom the primary cause of ESRD was not diabetic nephropathy.
d
Includes angina, previous myocardial infarction, or previous coronary revascularization.